Ligand Pharmaceuticals | LGND - EPS Earnings Per Share



Ligand Pharmaceuticals reported $1.6 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q2 Jun/2025 1.60 1.43 1.40 Aug/07 2025
FY2025Q1 Mar/2025 1.33 1.22 1.20 May/08 2025
FY2024Q4 Dec/2024 1.27 1.18 1.05 Feb/27 2025
FY2024Q3 Sep/2024 1.84 1.34 1.02 Nov/07 2024
FY2024Q2 Jun/2024 1.40 1.40 1.42 Aug/06 2024
FY2024Q1 Mar/2024 1.20 0.84 2.28 May/07 2024
FY2023Q4 Dec/2023 1.05 0.66 1.36 Feb/27 2024
FY2023Q3 Sep/2023 1.02 0.62 1.31 Nov/08 2023
FY2023Q2 Jun/2023 1.42 0.64 1.03 Aug/08 2023
FY2023Q1 Mar/2023 2.28 0.95 0.58 May/04 2023
FY2022Q4 Dec/2022 1.36 1.18 1.8 Feb/22 2023
FY2022Q3 Sep/2022 1.31 0.44 1.58 Nov/07 2022


Eps Change Date
Amgen USD 6.02 1.12 Jun/2025
Arrowhead Research USD -1.26 4.01 Jun/2025
Baxter International USD 0.59 0.04 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
GlaxoSmithKline GBP 0.47 0.02 Jun/2025
Glaxosmithkline USD 0.35 0.24 Jun/2025
Insmed USD -1.7 0.28 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Ligand Pharmaceuticals USD 1.6 0.27 Jun/2025
MacroGenics USD -0.57 0.32 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Veracyte USD 0.44 0.13 Jun/2025